Delayed graft function in renal transplantation

Current Opinion in Critical Care

Volumn 10, Issue 6, 2004, Pages 489-498

  Peeters, Patrick ^a   Terryn, Wim ^a   Vanholder, Raymond ^a   Lameire, Norbert ^a  

^a GHENT UNIVERSITY HOSPITAL   (Belgium)

Author keywords

Delayed graft function; Ischemia reperfusion; Kidney; Transplantation

Indexed keywords

HEAT SHOCK PROTEIN; HEME OXYGENASE 1;

ACUTE GRAFT REJECTION; GRAFT SURVIVAL; HEART BEAT; HEMODIALYSIS; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT; KIDNEY TRANSPLANTATION; MORBIDITY; PATHOPHYSIOLOGY; POSTOPERATIVE COMPLICATION; REVIEW; T LYMPHOCYTE;

EID: 10244229090     PISSN: 10705295     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.ccx.0000146119.46547.05     Document Type: Review

References (76)

1. Halloran PF, Hunsicker LG: Delayed graft function: state of the art, November 10-11, 2000. Summit meeting, Scottsdale, Arizona, USA. Am J Transplant 2001, 1:115-120.
2. Rodrigo E, Ruiz JC, Pinera C, et al.: Creatinine reduction ratio on post-transplant day two as criterion in defining delayed graft function. Am J Transplant 2004, 4:1163-1169. The article challenges the concept that only dialyzed DGF is deleterious. Nondialyzed slow graft failure is also important for later graft outcome.
3. Humar A, Ramcharan T, Kandaswamy R, et al.: Risk factors for slow graft function after kidney transplants: a multivariate analysis. Clin Transplant 2002, 16:425-429.
4. Brier ME, Ray PC, Klein JB: Prediction of delayed renal allograft function using an artificial neural network. Nephrol Dial Transplant 2003, 18:2655-2659.
5. Boom H, Mallat MJ, de Fijter JW, et al.: Delayed graft function influences renal function, but not survival. Kidney Int 2000, 58:859-866.
6. Irish WD, McCollum DA, Tesi RJ, et al.: Nomogram for predicting the likelihood of delayed graft function in adult cadaveric renal transplant recipients. J Am Soc Nephrol 2003, 14:2967-2974. The authors constructed a nomogram capable of predicting DGF. In clinical practice and for randomization into clinical studies, the article might have an impact.
7. Johnston TD, Thacker LR, Jeon H, et al.: Sensitivity of expanded-criteria donor kidneys to cold ischaemia time. Clin Transplant 2004, 18(Suppl 12):28-32.
8. Cecka JM: The UNOS Renal Transplant Registry. Clin Transplant 2002;1-20.
9. Schnuelle P, Yard BA, Braun C, et al.: Impact of donor dopamine on immediate graft function after kidney transplantation. Am J Transplant 2004, 4:419-426.
10. Tooher RL, Rao MM, Scott DF, et al.: A systematic review of laparoscopic live-donor nephrectomy. Transplantation 2004, 78:404-414. Review of the outcomes of laparoscopic live-donor nephrectomy.
11. Troppmann C, Ormond DB, Perez RV: Laparoscopic (vs open) live donor nephrectomy: a UNOS database analysis of early graft function and survival. Am J Transplant 2003, 3:1295-1301.
12. Brennan TV, Freise CE, Fuller TF, et al.: Early graft function after living donor kidney transplantation predicts rejection but not outcomes. Am J Transplant 2004, 4:971-979.
13. Oppenheimer F, Aljama P, Asensio PC, et al.: The impact of donor age on the results of renal transplantation. Nephrol Dial Transplant 2004, 19(Suppl 3):iii11-iii15.
14. Giessing M, Budde K, Fritsche L, et al.: "Old-for-old" cadaveric renal transplantation: surgical findings, perioperative complications and outcome. Eur Urol 2003, 44:701-708.
15. Kruger B, Zulke C, Fischereder M, et al.: Early experience with the ET Senior Program "Old For Old": better to be number one? Transpl Int 2002, 15:541-545.
16. Brook NR, White SA, Waller JR, et al.: Non-heart beating donor kidneys with delayed graft function have superior graft survival compared with conventional heart-beating donor kidneys that develop delayed graft function. Am J Transplant 2003, 3:614-618.
17. Cooper JT, Chin LT, Krieger NR, et al.: Donation after cardiac death: the University of Wisconsin experience with renal transplantation. Am J Transplant 2004, 4:1490-1494.
18. Gerstenkorn C, Deardon D, Koffman CG, et al.: Outcome of renal allografts from non-heart-beating donors with delayed graft function. Transpl Int 2002, 15:660-663.
19. Rudich SM, Kaplan B, Magee JC, et al.: Renal transplantations performed using non-heart-beating organ donors: going back to the future? Transplantation 2002, 74:1715-1720.
20. Sanchez-Fructuoso A, Prats SD, Marques VM, et al.: Non-heart beating donors. Nephrol Dial Transplant 2004, 19(Suppl 3):iii26-iii31.
21. Sudhindran S, Pettigrew GJ, Drain A, et al.: Outcome of transplantation using kidneys from controlled (Maastricht category 3) non-heart-beating donors. Clin Transplant 2003, 17:93-100.
22. Brook NR, Waller JR, Nicholson ML: Nonheart-beating kidney donation: current practice and future developments. Kidney Int 2003, 63:1516-1529. State of the art on NHBD.
23. Alfrey EJ, Boissy AR, Lerner SM: Dual-kidney transplants: long-term results. Transplantation 2003, 75:1232-1236.
24. Bunnapradist S, Gritsch HA, Peng A, et al.: Dual kidneys from marginal adult donors as a source for cadaveric renal transplantation in the United States. J Am Soc Nephrol 2003, 14:1031-1036.
25. McCall SJ, Tuttle-Newhall JE, Howell DN, et al.: Prognostic significance of microvascular thrombosis in donor kidney allograft biopsies. Transplantation 2003, 75:1847-1852.
26. Roodnat JI, van Riemsdijk IC, Mulder PG, et al.: The superior results of living-donor renal transplantation are not completely caused by selection or short cold ischemia time: a single-center, multivariate analysis. Transplantation 2003, 75:2014-2018.
27. Jassem W, Koo DD, Cerundolo L, et al.: Cadaveric versus living-donor livers: differences in inflammatory markers after transplantation. Transplantation 2003, 76:1599-1603. Study on human livers in cadaveric and living donors, showing an enhanced inflammatory status associated with brain death.
28. Sanchez-Fructuoso AI, Prats D, Marques M, et al.: Does donor brain death influence acute vascular rejection in the kidney transplant? Transplantation 2004, 78:142-146.
29. Kosieradzki M, Kuczynska J, Piwowarska J, et al.: Prognostic significance of free radicals: mediated injury occurring in the kidney donor. Transplantation 2003, 75:1221-1227.
30. Nijboer WN, Schuurs TA, van der Hoeven JAB, et al.: Effect of brain death and donor treatment on organ inflammatory response and donor organ viability. Curr Opin Organ Transplant 2004, 9:110-115. Comprehensive review of brain death and plausible pathways for therapeutic intervention.
31. Pratschke J, Volk HD: Brain death-associated ischemia and reperfusion injury. Curr Opin Organ Transplant 2004, 9:153-158. Comprehensive review of the importance of brain death as the start of ischemia/reperfusion injury.
32. Cavanaugh KL, Rabb H: T cells and signaling pathways in ischemia and reperfusion injury. Curr Opin Organ Transplant 2004, 9:132-138. Comprehensive review of T cells and signaling pathways, stressing the role of T cells in ischemia/reperfusion injury and providing further basic information on cell survival pathways.
33. Lemos FB, IJzermans JN, Zondervan PE, et al.: Differential expression of heme oxygenase-1 and vascular endothelial growth factor in cadaveric and living donor kidneys after ischemia-reperfusion. J Am Soc Nephrol 2003, 14:3278-3287. Identification and upregulation of cell survival pathways.
34. Vincentelli J, Luccioni A, Devictor B, et al.: Comparative study on two kidney graft rinsing and preservation solutions in terms of the post-transplantation risk of delayed graft function and cost. J Clin Pharm Ther 2003, 28:273-277.
35. Guarrera JV, Polyak M, O'Mar AB, et al.: Pulsatile machine perfusion with Vasosol solution improves early graft function after cadaveric renal transplantation. Transplantation 2004, 77:1264-1268.
36. Wamser P, Asari R, Goetzinger P, et al.: Detrimental effects of controlled reperfusion on renal function after porcine autotransplantation are fully compensated by the use of Carolina rinse solution. Transpl Int 2003, 16:191-196.
37. Hauet T, Han Z, Doucet C, et al.: A modified University of Wisconsin preservation solution with high-NA+ low-K+ content reduces reperfusion injury of the pig kidney graft. Transplantation 2003, 76:18-27.
38. Norio K, Wikstrom M, Salmela K, et al.: Ascorbic acid against reperfusion injury in human renal transplantation. Transpl Int 2003, 16:480-485.
39. Erkasap N, Ates E, Erkasap S, Kaygisiz Z: Lidocaine-containing Euro-Collins solution prevents renal injury in the isolated perfused canine kidney exposed to prolonged cold ischemia. Physiol Res 2002, 51:493-499.
40. Jani A, Ljubanovic D, Faubel S, et al.: Caspase inhibition prevents the increase in caspase-3, -2, -8 and -9 activity and apoptosis in the cold ischemic mouse kidney. Am J Transplant 2004, 4:1246-1254.
41. Wight JP, Chilcott JB, Holmes MW, et al.: Pulsatile machine perfusion vs. cold storage of kidneys for transplantation: a rapid and systematic review. Clin Transplant 2003, 17:293-307.
42. Arias M: Impact of the delayed graft function in hypersensitized kidney transplant patients. Transplant Proc 2003, 35:1655-1657.
43. McTaggart RA, Gottlieb D, Brooks J, et al.: Sirolimus prolongs recovery from delayed graft function after cadaveric renal transplantation. Am J Transplant 2003, 3:416-423.
44. Noreen HJ, McKinley DM, Gillingham KJ, et al.: Positive remote crossmatch: impact on short-term and long-term outcome in cadaver renal transplantation. Transplantation 2003, 75:501-505.
45. Sijpkens YW, Doxiadis II, Mallat MJ, et al.: Early versus late acute rejection episodes in renal transplantation. Transplantation 2003, 75:204-208.
46. Shilliday IR, Sherif M: Calcium channel blockers for preventing acute tubular necrosis in kidney transplant recipients. Cochrane Database Syst Rev 2004;CD003421.
47. Boom H, Mallat MJ, de Fijter JW, et al.: Calcium levels as a risk factor for delayed graft function. Transplantation 2004, 77:868-873.
48. Lorenz M, Billensteiner E, Bodingbauer M, et al.: The effect of ACE inhibitor and angiotensin II blocker therapy on early posttransplant kidney graft function. Am J Kidney Dis 2004, 43:1065-1070. Early introduction of ACEi and ARB, both blocking the renin-angiotensin system, has favorable effects on early graft function, in contrast to popular beliefs.
49. McTaggart RA, Tomlanovich S, Bostrom A, et al.: Comparison of outcomes after delayed graft function: sirolimus-based versus other calcineurin-inhibitor sparing induction immunosuppression regimens. Transplantation 2004, 78:475-480.
50. Stallone G, Di Paolo S, Schena A, et al.: Addition of sirolimus to cyclosporine delays the recovery from delayed graft function but does not affect 1-year graft function. J Am Soc Nephrol 2004, 15:228-233.
51. Smith KD, Wrenshall LE, Nicosia RF, et al.: Delayed graft function and cast nephropathy associated with tacrolimus plus rapamycin use. J Am Soc Nephrol 2003, 14:1037-1045.
52. Fuller TF, Freise CE, Serkova N, et al.: Sirolimus delays recovery of rat kidney transplants after ischemia-reperfusion injury. Transplantation 2003, 76:1594-1599.
53. Gonwa T, Johnson C, Ahsan N, et al.: Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years. Transplantation 2003, 75:2048-2053.
54. Ekberg H, Persson NH, Kallen R, et al.: Two doses of daclizumab in conjunction with low-dose cyclosporine, mycophenolate mofetil and steroids resulted in a low incidence of acute rejection after renal transplantation. Scand J Immunol 2003, 58:670-677.
55. Sanchez-Fructuoso AI, Prats D, Marques M, et al.: Daclizumab induction as an immunosuppressive regimen for renal transplant recipients from non-heart-beating donors. Transplant Proc 2003, 35:1689-1690.
56. Heifets M, Saeed MI, Parikh MH, et al.: Induction immunosuppression in kidney transplant recipients older than 60 years of age: safety and efficacy of ATGAM((R)), OKT3((R)) and Simulect((R)). Drugs Aging 2004, 21:747-756.
57. Goggins WC, Pascual MA, Powelson JA, et al: A prospective, randomized, clinical trial of intraoperative versus postoperative thymoglobulin in adult cadaveric renal transplant recipients. Transplantation 2003, 76:798-802. Intraoperative versus delayed introduction of polyclonal antibody therapy conveys beneficial effects and is an in vivo proof of the noxious effect of infiltrating T cells into the graft.
58. Kasiske BL, Anjum S, Shah R, et al.: Hypertension after kidney transplantation. Am J Kidney Dis 2004, 43:1071-1081.
59. Thomas MC, Mathew TH, Russ GR, et al.: Perioperative blood pressure control, delayed graft function, and acute rejection after renal transplantation. Transplantation 2003, 75:1989-1995.
60. Espejo B, Torres A, Valentin M, et al.: Obesity favors surgical and infectious complications after renal transplantation. Transplant Proc 2003, 35:1762-1763.
61. Akalin E, Neylan JF: The influence of Duffy blood group on renal allograft outcome in African Americans. Transplantation 2003, 75:1496-1500.
62. McDaniel DO, Barber WH, Nguyen C, et al.: Combined analysis of cytokine genotype polymorphism and the level of expression with allograft function in African-American renal transplant patients. Transpl Immunol 2003, 11:107-119.
63. Kwon O, Molitoris BA, Pescovitz M, et al.: Urinary actin, interleukin-6, and interleukin-8 may predict sustained ARF after ischemic injury in renal allografts. Am J Kidney Dis 2003, 41:1074-1087.
64. Parikh CR, Jani A, Melnikov VY, et al.: Urinary interleukin-18 is a marker of human acute tubular necrosis. Am J Kidney Dis 2004, 43:405-414.
65. Gill JS, Pereira BJ: Death in the first year after kidney transplantation: implications for patients on the transplant waiting list. Transplantation 2003, 75:113-117. The importance of DGF is stressed in this article because an increase in death rate is observed in recipients of DGF organs.
66. Ponticelli C, Villa M, Cesana B, et al.: Risk factors for late kidney allograft failure. Kidney Int 2002, 62:1848-1854.
67. Carlier M, Squifflet JP, Pirson Y, et al.: Maximal hydration during anesthesia increases pulmonary arterial pressures and improves early function of human renal transplants. Transplantation 1982, 34:201-204.
68. Carlier M, Squifflet JP, Pirson Y, et al.: Confirmation of the crucial role of the recipient's maximal hydration on early diuresis of the human cadaver renal allograft. Transplantation 1983, 36:455-456.
69. Vanholder R, Heering P, Loo AV, et al.: Reduced incidence of acute renal graft failure in patients treated with peritoneal dialysis compared with hemodialysis. Am J Kidney Dis 1999, 33:934-940.
70. Van Biesen W, Vanholder R, Van Loo A, et al.: Peritoneal dialysis favorably influences early graft function after renal transplantation compared to hemodialysis. Transplantation 2000, 69:508-514.
71. Van Valenberg PLJ, Hoitsma A, Tiggeler RWGL, et al.: Mannitol as an indispensable constituent of an intravenous hydration protocol for the prevention of acute renal failure after cadaveric renal transplantation. Transplantation 1987, 44:784-788.
72. Grino JP, Miravittles R, Castelao AM: Flush solution with mannitol in the prevention of post-transplant renal failure. Transplant Proc 1987, 19:4140-4142.
73. Ratcliffe PJ, Richardson AJ, Kirby JE, et al.: Effect of intravenous infusion of atriopeptin 3 on immediate renal allograft function. Kidney Int 1991, 39:164-168.
74. Sands JM, Neylan JF, Olson RA, et al.: Atrial natriuretic factor does not improve the outcome of cadaveric renal transplantation. J Am Soc Nephrol 1991, 1:1081-1086.
75. Cittanova ML, Leblanc I, Legendre C, et al.: Effect of hydroxyethyl starch in brain-dead kidney donors on renal function in kidney-transplant recipients. Lancet 1996, 348:1620-1622.
76. Deman A, Peeters P, Sennesael J: Hydroxyethyl starch does not impair immediate renal function in kidney transplant recipients: a retrospective, multi-centre analysis. Nephrol Dial Transplant 1999, 14:1517-1520.